Menopausal Hormone Therapy (MHT) is having a new moment in its long history of use and research. The last 22 years since the publication of the first paper from the Women’s Health Initiative (WHI) created what seemed like a permanent dark mark on the use of hormones to lessen menopausal symptoms. Researchers and clinicians who have kept up to date with research in the last 22 years and longer have realised its benefits and select risks and didn’t agree with the across-the-board dark mark against it. In fact, they understood and prescribed appropriately for its benefits when it was not contraindicated or when it posed more than comfortable risks.
Now, we see the opposite problem, in which uninformed clinicians, patients, and consumers think MHT is the right choice for all perimenopausal and menopausal women at any time and at any age.
In this webinar, we will discuss:
- The myths and misconceptions of MHT in perimenopausal and menopausal women
- The benefits and risks of MHT
- The importance of using MHT with caution and prioritising individualised treatment
